2021-06-27 21:10 With years of experience and a broad portfolio of past studies on SARS-CoV and MERS-CoV, Creative Biolabs has cultivated solid expertise in the fields of virology and epidemiology. At present, our virologists have obtained enough evidence to speculate that an anti-inflammatory drug, indomethacin (INDO), has great potential and is expected to be the next drug candidate for SARS-CoV-2.
Вы можете показать это желание на своем сайте, в блоге, в форуме и т.д., скопировав и вставив туда этот HTML-код.
